Amylyx Pharmaceuticals Completes $575 Million Upsized Public Offering of Common Stock

Goodwin Procter LLP has advised Amylyx Pharmaceuticals, Inc. Wilmer Cutler Pickering Hale and Dorr LLP has advised the underwriters. Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) has completed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here